The Impact of Genetic Variation and Gene Expression Level of The Follicle-Stimulating Hormone Receptor on Ovarian Reserve

Objective Ovarian reserve is defined as the capacity of the ovary to provide fertile oocytes. Diminished ovarian reserve (DOR) is a disorder in which ovaries are prone to go through early menopause. Where this loss of function occurs before the age of 40, it results in the premature ovarian failure...

Full description

Bibliographic Details
Main Authors: Zeinab Ghezelayagh, Mehdi Totonchi, Shabnam Zarei-Moradi
Format: Article
Language:English
Published: Royan Institute (ACECR), Tehran 2017-11-01
Series:Cell Journal
Subjects:
Online Access:http://celljournal.org/journal/article/16359/download
id doaj-c7dce0a3d83e4802afe8287ea7f707f2
record_format Article
spelling doaj-c7dce0a3d83e4802afe8287ea7f707f22020-11-25T00:47:46ZengRoyan Institute (ACECR), TehranCell Journal2228-58062228-58142017-11-0119462062610.22074/cellj.2018.4183The Impact of Genetic Variation and Gene Expression Level of The Follicle-Stimulating Hormone Receptor on Ovarian ReserveZeinab Ghezelayagh0Mehdi Totonchi1Shabnam Zarei-Moradi2University of Science and Culture, Faculty of Basic Sciences and Advanced Technologies in Biology, ACECR, Tehran, IranDepartment of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, IranDepartment of Genetics, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Tehran, IranObjective Ovarian reserve is defined as the capacity of the ovary to provide fertile oocytes. Diminished ovarian reserve (DOR) is a disorder in which ovaries are prone to go through early menopause. Where this loss of function occurs before the age of 40, it results in the premature ovarian failure (POF) disease. Throughout folliculogenesis, the follicle-stimulating hormone receptor (FSHR) starts a signaling cascade in the granulosa cells where its inactivation leads to the arrest of follicle maturation and therefore adversely affects ovarian reserve. The aim of this study was to investigate the association of genetic variation (polymorphisms and inactivating mutations) of FSHR with POF and DOR. Materials and Methods This case-control study comprised 84 POF, 52 DOR and 80 fertile Iranian women. To determine the presence of the 566C>T mutation and the -29G>A polymorphism in FSHR, PCR-RFLP method was used. SSCP-sequencing was used to identify any allelic variants in exon 10. The expression of human FSHR at the transcript level was also compared between DOR and fertile controls by real time-polymerase chain reaction (PCR). Results The 566C>T polymorphism was normal in all the cases. All genotypes of -29G>A and 919G>A (exon 10) polymorphisms were observed. Statistically significant differences were seen in the genotypic distribution of both polymorphisms when comparing the control group with the DOR patient group. A decrease was observed in FSHR expression of DOR patients compared with the control group but was not significant. Conclusion We conclude that the -29G>A and 919G>A polymorphisms in FSHR may be associated with DOR. Although these polymorphisms had significant differences at the genic level, no significant variation was found at the transcript level.http://celljournal.org/journal/article/16359/downloadAllelic VariantsFollicle Stimulating Hormone ReceptorPremature Ovarian Failure
collection DOAJ
language English
format Article
sources DOAJ
author Zeinab Ghezelayagh
Mehdi Totonchi
Shabnam Zarei-Moradi
spellingShingle Zeinab Ghezelayagh
Mehdi Totonchi
Shabnam Zarei-Moradi
The Impact of Genetic Variation and Gene Expression Level of The Follicle-Stimulating Hormone Receptor on Ovarian Reserve
Cell Journal
Allelic Variants
Follicle Stimulating Hormone Receptor
Premature Ovarian Failure
author_facet Zeinab Ghezelayagh
Mehdi Totonchi
Shabnam Zarei-Moradi
author_sort Zeinab Ghezelayagh
title The Impact of Genetic Variation and Gene Expression Level of The Follicle-Stimulating Hormone Receptor on Ovarian Reserve
title_short The Impact of Genetic Variation and Gene Expression Level of The Follicle-Stimulating Hormone Receptor on Ovarian Reserve
title_full The Impact of Genetic Variation and Gene Expression Level of The Follicle-Stimulating Hormone Receptor on Ovarian Reserve
title_fullStr The Impact of Genetic Variation and Gene Expression Level of The Follicle-Stimulating Hormone Receptor on Ovarian Reserve
title_full_unstemmed The Impact of Genetic Variation and Gene Expression Level of The Follicle-Stimulating Hormone Receptor on Ovarian Reserve
title_sort impact of genetic variation and gene expression level of the follicle-stimulating hormone receptor on ovarian reserve
publisher Royan Institute (ACECR), Tehran
series Cell Journal
issn 2228-5806
2228-5814
publishDate 2017-11-01
description Objective Ovarian reserve is defined as the capacity of the ovary to provide fertile oocytes. Diminished ovarian reserve (DOR) is a disorder in which ovaries are prone to go through early menopause. Where this loss of function occurs before the age of 40, it results in the premature ovarian failure (POF) disease. Throughout folliculogenesis, the follicle-stimulating hormone receptor (FSHR) starts a signaling cascade in the granulosa cells where its inactivation leads to the arrest of follicle maturation and therefore adversely affects ovarian reserve. The aim of this study was to investigate the association of genetic variation (polymorphisms and inactivating mutations) of FSHR with POF and DOR. Materials and Methods This case-control study comprised 84 POF, 52 DOR and 80 fertile Iranian women. To determine the presence of the 566C>T mutation and the -29G>A polymorphism in FSHR, PCR-RFLP method was used. SSCP-sequencing was used to identify any allelic variants in exon 10. The expression of human FSHR at the transcript level was also compared between DOR and fertile controls by real time-polymerase chain reaction (PCR). Results The 566C>T polymorphism was normal in all the cases. All genotypes of -29G>A and 919G>A (exon 10) polymorphisms were observed. Statistically significant differences were seen in the genotypic distribution of both polymorphisms when comparing the control group with the DOR patient group. A decrease was observed in FSHR expression of DOR patients compared with the control group but was not significant. Conclusion We conclude that the -29G>A and 919G>A polymorphisms in FSHR may be associated with DOR. Although these polymorphisms had significant differences at the genic level, no significant variation was found at the transcript level.
topic Allelic Variants
Follicle Stimulating Hormone Receptor
Premature Ovarian Failure
url http://celljournal.org/journal/article/16359/download
work_keys_str_mv AT zeinabghezelayagh theimpactofgeneticvariationandgeneexpressionlevelofthefolliclestimulatinghormonereceptoronovarianreserve
AT mehditotonchi theimpactofgeneticvariationandgeneexpressionlevelofthefolliclestimulatinghormonereceptoronovarianreserve
AT shabnamzareimoradi theimpactofgeneticvariationandgeneexpressionlevelofthefolliclestimulatinghormonereceptoronovarianreserve
AT zeinabghezelayagh impactofgeneticvariationandgeneexpressionlevelofthefolliclestimulatinghormonereceptoronovarianreserve
AT mehditotonchi impactofgeneticvariationandgeneexpressionlevelofthefolliclestimulatinghormonereceptoronovarianreserve
AT shabnamzareimoradi impactofgeneticvariationandgeneexpressionlevelofthefolliclestimulatinghormonereceptoronovarianreserve
_version_ 1725258653897850880